Oncology Active Pharmaceutical Ingredient Market Analysis

Type of Cancer (Breast, Cervical, Lung, Liver, Colorectal)

The global oncology active pharmaceutical ingredient (API) market is segmented and analyzed for demand and supply by type of cancer into breast, cervical, lung, liver, colorectal, and others. Amongst these segments, the breast cancer segment is projected to acquire the largest market share over the forecast period on the back of rising cases of breast cancer. World Health Organization (WHO) showed that in 2020 around 2.26 million cases of breast cancer were diagnosed across the globe. The rising number of deaths owing to breast cancer along with the increased difficulties among patients owing to breast cancer is estimated to increase the demand for oncology active pharmaceutical ingredients in the next few years.

APIs (Innovative Oncology APIs, Generic Oncology APIs)

The global oncology active pharmaceutical ingredient (API) market is also segmented and analyzed for demand and supply by synthesis type into synthetic oncology APIs, and biotech oncology APIs. Out of these two segments, the synthetic oncology APIs segment is anticipated to garner the highest market share owing to the high advantages and benefits offered by them. Low cost for manufacturing synthetic oncology active pharmaceutical ingredients owing to the fewer costs of the raw materials used is considered to be the major factor for segment expansion. Furthermore, the easy process of manufacturing coupled with less complex processes is another factor that is projected to create a positive outlook for segment growth during the analysis period.

Our in-depth analysis of the global market includes the following segments: